TipRanks
Go Ultimate55% OFF

Circassia Pharmaceuticals (82C) Q4 2025 Earnings Report

DE:82C Q4 2025 EPS Results

Actual EPS
EUR 0.00
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
EUR 0.00

DE:82C Q4 2025 Revenue Results

Actual Revenue
EUR 27.42M
Expected Revenue
EUR 27.42M
Beat/Miss
Met expectations
YoY Revenue Growth
+12.98%

Earnings Announcement Details

Quarter
Q4 2025
Date
03/24/2026
Time
Before Open
Conference Call
Tuesday, March 24, 2026
DE:82C Upcoming Earnings

Circassia Pharmaceuticals's next earnings date is estimated for March 23, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:82C Earnings History

DE:82C earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 23, 20272026 (Q4)0.01-0――
Sep 29, 20262026 (Q2)0.020.020.020.00% (+0.00)
Mar 24, 20262025 (Q4)―0.000250.00% (+0.01)
Sep 30, 20252025 (Q2)―0.020.0140.00% (+0.00)
Apr 01, 20252024 (Q4)―-0.000.02-111.76% (-0.02)
Sep 24, 20242024 (Q2)―0.010.0166.67% (+0.00)
Mar 26, 20242023 (Q4)―0.020.026.25% (+0.00)
Sep 26, 20232023 (Q2)―0.010.02-71.43% (-0.02)
Mar 21, 20232022 (Q4)―0.020.0145.45% (+0.01)
Sep 14, 20222022 (Q2)―0.020―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More